This remarkable cancer-type specificity of HIF2α oncogenic activity reinforces the view that its role is highly context-dependent, and that in neuroblastoma, lacking VHL mutations, HIF2α may serve a different, potentially tumor-suppressive function. This evidence concerns the gene EPAS1 and neoplasm.